The Safety of Recently Approved Therapeutics in Age-Related Macular Degeneration.
Khanani I, Aziz AA, Khanani ZA, Khan H, Mojumder O, Sulahria H, Ali H, Khan H, Rahimzadeh TS, Vannavong J, Gahn GM, Khanani AM.
Khanani I, et al.
Int Ophthalmol Clin. 2025 Jan 1;65(1):3-7. doi: 10.1097/IIO.0000000000000547. Epub 2024 Dec 23.
Int Ophthalmol Clin. 2025.
PMID: 39710898
Review.
In nAMD, the newest agents approved by the FDA are brolucizumab (Novartis Pharmaceuticals, Basel, Switzerland), faricimab (F. Hoffman-La Roche, Basel, Switzerland), aflibercept 8 mg (Regeneron Pharmaceuticals, Tarrytown, NY, USA), and a new device in the port delivery syst …
In nAMD, the newest agents approved by the FDA are brolucizumab (Novartis Pharmaceuticals, Basel, Switzerland), faricimab (F. Hoffman …